Taking a closer look at delta as it applies to options trading as the Delta variant of Covid-19 pandemic ensues ...

Yahoo Finance Markets and Data Editor Jared Blikre, who also hosts Yahoo Finance's Stocks in Translation podcast, explains ...

Investing.com -- Tvardi Therapeutics (NASDAQ:TVRD) stock plunged 30% after the company reported disappointing preliminary data from its Phase 2 REVERT trial evaluating TTI-101 in idiopathic pulmonary ...

Monopar Therapeutics Inc. (NASDAQ: MNPR) is one of the best hot stocks to invest in. On October 6, Raymond James raised the ...

Investing.com -- Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) stock soared 100% in after-hours trading on Thursday after the company announced it received FDA Fast Track Designation for its AlloNK ...

Tvardi Therapeutics (TVRD) on Monday said that its TTI-101, being evaluated in idiopathic pulmonary fibrosis (IPF), showed no ...

While investors chase the usual market darlings, a few underappreciated businesses are quietly gaining traction by generating ...

Investing.com -- IsoEnergy Ltd. (NYSE:ISOU) stock gained 4.8% on Monday after the company announced it has entered into an ...

Trade negotiations with Canada are "back on track," according to Treasury Secretary Scott Bessent. President Trump had a "very good meeting" with Canadian Prime Minister Mark Carney, Bessent told CNBC ...

OPKO Health, Inc. is refocusing on drug development, selling BioReference Lab assets to strengthen its balance sheet. Learn ...

New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for ...